Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Giovanni Di Napoli
Andrea Cherubini
Dominika Spilarova
Egle Gedrimaite
Federico Sommariva
Luigi Longo
Nhan Ngo Dingh
Silvia Miliani
Svetlana Sigalova
Board:
Alessandro Chà
Maria Grazia Roncarolo
John O'Dea
Mauro Ajani
Niall Donnelly
Silvana Perretta
Shareholding in %:
BlackRock Fund Advisors 0.69
Capital Research & Management Co. (World Investors) 5.42
Cosmo NV 2.99
Gerald Herz 8
JPMorgan Asset Management (UK) Ltd. 0.69
Mauro Severino Ajani 35.04
UBS Asset Management Switzerland AG 3.24
Vanguard Capital Management LLC 1.4
Zürcher Kantonalbank (Investment Management) 1.26
dievini Hopp BioTech holding GmbH & Co. KG 3.8
Freefloat 37.48
Address: Riverside II, Sir John Rogerson's Quay, 2 Dublin
T: +353-1-8170370
F: +353-1-8230718
I: http://www.cosmopharma.com
E: